Cutaneous Oncology in the Immunosuppressed
- PMID: 36410975
- DOI: 10.1016/j.det.2022.07.012
Cutaneous Oncology in the Immunosuppressed
Abstract
Patients with immunosuppressive conditions experience an increased frequency and severity of cutaneous malignancies. This article highlights management of keratinocyte carcinoma, melanoma, Merkel cell carcinoma, and Kaposi sarcoma in the setting of lymphoproliferative disorders, acquired immunodeficiencies, and organ transplantation. Advances in the safety of organ transplant recipient immunosuppression, early identification of risk factors, and new targeted therapies are improving skin cancer outcomes in immunocompromised populations.
Keywords: Chronic lymphocytic leukemia; HIV; Immunosuppression; Kaposi sarcoma; Keratinocyte carcinoma; Melanoma; Merkel cell carcinoma; Organ transplant recipients.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of Interest/Funding Disclosures None.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical